217 related articles for article (PubMed ID: 9036657)
1. [Inhalation and peroral mucolytic therapy in mucoviscidosis in children].
Uglitskikh AK; Khan MA; Sharapov SV; Kapranov NI; Plisko LF
Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):15-8. PubMed ID: 9036657
[TBL] [Abstract][Full Text] [Related]
2. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Nash EF; Stephenson A; Ratjen F; Tullis E
Cochrane Database Syst Rev; 2009 Jan; (1):CD007168. PubMed ID: 19160327
[TBL] [Abstract][Full Text] [Related]
3. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Tam J; Nash EF; Ratjen F; Tullis E; Stephenson A
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007168. PubMed ID: 23852992
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride).
Dietzsch HJ; Gottschalk B; Heyne K; Leupoid W; Wunderlich P
Pediatrics; 1975 Jan; 55(1):96-100. PubMed ID: 1110869
[TBL] [Abstract][Full Text] [Related]
5. [Outcomes of the long-term treatment with a novel mucolytic drug pulmozin in mucoviscidosis patients].
Kapranov NI; Gembitskaia TE; Simonova OI; Amelina EL; Kovaleva LF; Shabalova LA; Kashirskaia NIu; Faustova ME
Ter Arkh; 2001; 73(1):55-8. PubMed ID: 11234144
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the effect of repeated peroral administration of 3 mucolytic agents on the ultrastructure of the epithelium in the respiratory tract].
Konrádová V; Vávrová V; Sulová J
Cesk Pediatr; 1985 Oct; 40(10):565-8. PubMed ID: 3933839
[No Abstract] [Full Text] [Related]
7. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
8. [Carbocysteine--an effective mucolytic in cystic fibrosis of the lungs].
Hruskovic I; Brezina M; Kayserová H; Langsádl L; Cervenka J
Cesk Pediatr; 1988 Oct; 43(10):602-4. PubMed ID: 3208328
[No Abstract] [Full Text] [Related]
9. In celebration of expectoration: induced sputum indices as outcome measures in cystic fibrosis.
Armstrong DS
Am J Respir Crit Care Med; 2003 Dec; 168(12):1412-3. PubMed ID: 14668253
[No Abstract] [Full Text] [Related]
10. Effects and mechanisms of ambroxol inhalation (Mucosolvan
Yang Z; Xiao X; Huang Y; He X; Lu Q; Chen S; Lin Z
Pharmazie; 2017 Oct; 72(10):604-607. PubMed ID: 29441886
[TBL] [Abstract][Full Text] [Related]
11. [Mucolytics and expectorants - a critical review on their differentiated application (author's transl)].
Steffen R
Schweiz Rundsch Med Prax; 1976 Jan; 65(1):24-9. PubMed ID: 1250820
[No Abstract] [Full Text] [Related]
12. Acetylcysteine in the oral mucolytic treatment of cystic fibrosis.
Stephan U; Böwing B; Goering U; Wiesemann HG; Reinhardt M; Hirche H; Brandt H
Eur J Respir Dis Suppl; 1980; 111():127-31. PubMed ID: 6938396
[No Abstract] [Full Text] [Related]
13. The role of nebuliser therapy in cystic fibrosis.
Geddes D
Prof Care Mother Child; 1995; 5(6):147, 149. PubMed ID: 8680235
[No Abstract] [Full Text] [Related]
14. [Remarks on mucolytic agents (preliminary note)].
Perfumo F; Romano C
Fracastoro; 1970; 63(3):477-8. PubMed ID: 5517024
[No Abstract] [Full Text] [Related]
15. [Peroral therapy with expectorants].
Lunichkina IV; Solopov VN
Klin Med (Mosk); 1988 Dec; 66(12):59-62. PubMed ID: 3230852
[No Abstract] [Full Text] [Related]
16. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
[TBL] [Abstract][Full Text] [Related]
17. [Changes in sputum in catarrhal bronchitis in children after treatment with S-carboxymethylcysteine (viscosimetric studies)].
Castello D; Costa G; De Candussio G
Minerva Pediatr; 1979 Mar; 31(5):371-80. PubMed ID: 460097
[No Abstract] [Full Text] [Related]
18. Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis.
Mateos-Corral D; Cutz E; Solomon M; Ratjen F
Pediatr Pulmonol; 2009 Sep; 44(9):939-40. PubMed ID: 19658112
[TBL] [Abstract][Full Text] [Related]
19. [Medical treatment of seromucous otitis].
Renou G; Ketari M; Toutée JP; Benzaken J
Rev Laryngol Otol Rhinol (Bord); 1989; 110(3):327-8. PubMed ID: 8638061
[TBL] [Abstract][Full Text] [Related]
20. The management of cystic fibrosis with carbocysteine lysine salt: single-blind comparative study with ambroxol hydrochloride.
Caramia G; Gagliardini R; Ruffini E; Osimani P; Nobilini A
J Int Med Res; 1995; 23(4):284-93. PubMed ID: 7589772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
